New Horizon Health, a Chinese company that primarily develops cancer detection and screening products, unveiled on Friday that it has secured US$66 million in a series C round of financing led by Hong Kong-based private equity firm VMS Investment Group.
SoftBank-Backed Chinese Cancer Detection Products Developer Gets $66M Fresh Funds comes originally from China Money Network. All Rights Reserved.